Literature DB >> 26415087

Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma.

Zi-Zhen Xu1,2, Wan-Bin Fu2, Zhen Jin2, Pei Guo2, Wen-Fang Wang2, Jun-Min Li1.   

Abstract

This study investigated the cytotoxic effect of oridonin (ORI), a diterpenoid isolated from Rabdosia rubescens, in human diffuse large B cell lymphoma (DLBCL) in vitro and in vivo and the potential molecular mechanisms for ORI-induced cell apoptosis. ORI treatment caused reactive oxygen species (ROS)-mediated oxidative DNA damage response (DDR) and the c-Jun N-terminal kinase (JNK) pathway activation, leading to an induction of intrinsic apoptosis. ROS abolition blocked ORI-induced apoptosis and attenuated the expression of phospho-histone H2AX and phospho-JNK, indicating that ROS-mediated DNA damage and JNK pathway activation were involved in ORI-induced apoptosis. The systemic administration of ORI suppressed the growth of human DLBCL xenografts without showing significant toxicity. These findings suggest that ORI may have promising therapeutic application in DLBCL.

Entities:  

Keywords:  Apoptosis; DNA damage response; JNK; diffuse large B cell lymphoma; oridonin; reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 26415087     DOI: 10.3109/10428194.2015.1061127

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads.

Authors:  Ye Ding; Dengfeng Li; Chunyong Ding; Pingyuan Wang; Zhiqing Liu; Eric A Wold; Na Ye; Haiying Chen; Mark A White; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2018-03-20       Impact factor: 7.446

2.  Synergistic effect of oridonin and a PI3K/mTOR inhibitor on the non-germinal center B cell-like subtype of diffuse large B cell lymphoma.

Authors:  Kai Qing; Zhen Jin; Wanbin Fu; Wenfang Wang; Zhao Liu; Xiaoyang Li; Zizhen Xu; Junmin Li
Journal:  J Hematol Oncol       Date:  2016-08-23       Impact factor: 17.388

3.  Mitochondrial ROS contribute to oridonin-induced HepG2 apoptosis through PARP activation.

Authors:  Xiaoning Liu; Jingjing Kang; Hui Wang; Tao Huang
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

4.  Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.

Authors:  Ying Lu; Yang Sun; Jianwei Zhu; Lisha Yu; Xiubo Jiang; Jie Zhang; Xiaochen Dong; Bo Ma; Qi Zhang
Journal:  Cell Death Dis       Date:  2018-01-11       Impact factor: 8.469

5.  Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count.

Authors:  Yan-Li Li; Zhi-Hu Shi; Xian Wang; Kang-Sheng Gu; Zhi-Min Zhai
Journal:  BMC Cancer       Date:  2019-11-06       Impact factor: 4.430

6.  Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression.

Authors:  Bin-Hua Zou; Yan-Hui Tan; Wen-de Deng; Jie-Huang Zheng; Qin Yang; Min-Hong Ke; Zong-Bao Ding; Xiao-Juan Li
Journal:  Acta Pharmacol Sin       Date:  2020-08-04       Impact factor: 6.150

Review 7.  Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.

Authors:  Xiang Li; Chuan-Tao Zhang; Wei Ma; Xin Xie; Qun Huang
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.